Reply: A suggested classification of disease behaviour and treatment response in sarcoidosis trials
- PMID: 38237998
- DOI: 10.1183/13993003.02208-2023
Reply: A suggested classification of disease behaviour and treatment response in sarcoidosis trials
Conflict of interest statement
Conflict of interest: The authors have no potential conflicts of interest to disclose.
Comment on
-
High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).Eur Respir J. 2023 Sep 9;62(3):2300198. doi: 10.1183/13993003.00198-2023. Print 2023 Sep. Eur Respir J. 2023. PMID: 37690784 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical